Crinetics Pharmaceuticals (CRNX) Return on Capital Employed (QoQ) (2018 - 2026)
Crinetics Pharmaceuticals (CRNX) Return on Capital Employed (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - |
| 2 | Nanobiotix | 1,899.87 Bn | 1,899.81 Bn | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - |
| 4 | BeOne Medicines | 470.43 Bn | 465.64 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.43 Bn | 116.19 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.20 Bn | 61.44 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.75 Bn | 61.75 Bn | - |
| 8 | Argenx Se | 56.15 Bn | 50.96 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn |
| 10 | Crinetics Pharmaceuticals | 8.72 Bn | 7.43 Bn | 10.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 227.00 |
| Dec 31, 2025 | -713.00 |
| Sep 30, 2025 | -723.00 |
| Jun 30, 2025 | -555.00 |
| Mar 31, 2025 | 199.00 |
| Dec 31, 2024 | 466.00 |
| Sep 30, 2024 | -395.00 |
| Jun 30, 2024 | 207.00 |
| Mar 31, 2024 | 458.00 |
| Dec 31, 2023 | 1,116.00 |
| Sep 30, 2023 | 2,223.00 |
| Jun 30, 2023 | -1,150.00 |
| Mar 31, 2023 | -1,008.00 |
| Dec 31, 2022 | -934.00 |
| Sep 30, 2022 | -134.00 |
| Jun 30, 2022 | -173.00 |
| Mar 31, 2022 | 392.00 |
| Dec 31, 2021 | 836.00 |
| Sep 30, 2021 | 92.00 |
| Jun 30, 2021 | -99.00 |